Archives: Resources

Technology is enabling CRAs to focus their efforts on individual sites to avoid future issues and deliver high-quality results.

Trends in Medicine article covering a variety of general neuroscience trends and topics.

International Clinical Trials article discussing a rigorous protocol risk assessment method to design customized, adaptive monitoring plans.

PPD® Consulting offers insights on orphan drugs.

Contract Pharma article about how PPD employs flow cytometry in its development of biomarker assays for client studies.

Clinical trial demands are high for the growing expertise in Asian countries.

A brief background of REMS programs; dramatic shifts in the types of REMS approved; challenges associated with multi-sponsor REMS; and how to ensure that your company and products are prepared.

Jürgen Hummel, PPD’s associate statistical science director, was featured in the June issue of PharmaVOICE.